People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adimab, Inc. | — | Biotechnology | Series A | $12.2M | $144.6M | 2009 |
Bill L. Maris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bill L. Maris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Errik B. Anderson | 1 | 5 |
| Tillman U. Gerngross | 1 | 5 |
| Robert L. Birnbaum | 1 | 4 |
| Terrance L. McGuire | 1 | 3 |
| Michael L. Ross | 1 | 3 |
| William J Maris | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.